Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cytoplasmic P120ctn Promotes Gefitinib Resistance in Lung Cancer Cells by Activating PAK1 and ERK Pathway

Cytoplasmic P120ctn Promotes Gefitinib Resistance in Lung Cancer Cells by Activating PAK1 and ERK... Supplemental Digital Content is available in the text. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry Wolters Kluwer Health

Cytoplasmic P120ctn Promotes Gefitinib Resistance in Lung Cancer Cells by Activating PAK1 and ERK Pathway

Loading next page...
 
/lp/wolters-kluwer-health/cytoplasmic-p120ctn-promotes-gefitinib-resistance-in-lung-cancer-cells-vLA1wRQwEy

References (35)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1062-3345
eISSN
1533-4058
DOI
10.1097/pai.0000000000000965
Publisher site
See Article on Publisher Site

Abstract

Supplemental Digital Content is available in the text.

Journal

Applied ImmunohistochemistryWolters Kluwer Health

Published: Nov 19, 2021

There are no references for this article.